For Year 2025-26, Supriya Lifescience reports the following shareholding: Total Promoters at 68.3%, Mutual Fund at 0.67%, Insurance at 2.32%, Foreign Institutional Investors at 5.19%, Domestic Institutional Investors at 2.03%, and Retail at 21.5%. This breakdown provides a quick snapshot of ownership distribution for Supriya Lifescience in 2025-26.